Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma

被引：3
作者：
Zhao, Shuang [1 ]
Liu, Yanyan [1 ]
Yao, Zhihua [2 ]
Yan, Zheng [3 ]
Yao, Shuna [1 ]
Chu, Junfeng [1 ]
Wang, Haiying [1 ]
Zhang, Jiuyang [1 ]
Zhang, Peipei [1 ]
Zhou, Wenping [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Internal Med, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Internal Med, Affiliated Canc Hosp, Zhengzhou, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166829
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6579 / 6580
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of camrelizumab combined with chemotherapy (irinotecan combined with platinum) followed by camrelizumab combined with apatinib in the first-line treatment of advanced small cell lung cancer: A phase II study.
    Ni, Jun
    Zhang, Xiaotong
    Pan, Ruili
    Wang, Hanping
    Si, Xiaoyan
    Cui, Xiaoxia
    Zhang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
    Chu, Yunqian
    He, Xuan
    Xue, Ya
    Jiang, Hua
    Zhu, Chan
    Qi, Chunjian
    Zhang, Xing
    Chen, Dongsheng
    Dai, Hanjue
    Xian, Qingying
    Zhu, Wenyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] A phase II trial of first-line FOLFIRINOX for patients with advanced gastroesophageal adenocarcinoma
    Park, Haeseong
    Wang-Gillam, Andrea
    Suresh, Rama
    Rigden, Caron E.
    Amin, Manik A.
    Tan, Benjamin R.
    Pedersen, Katrina
    Lim, Kian-Huat
    Trikalinos, Nikolaos
    Navo, Katherine
    Morton, Ashley
    Schrumpf, Lindsey
    Marquez, Samantha
    Trinkaus, Kathryn
    Lockhart, A. Craig
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [24] First-line Treatment With Capecitabine Combined With Irinotecan in Patients With Advanced Colorectal Carcinoma A Phase II Study
    Assy, Nimer
    Basher, Walid
    Chetver, Lika
    Shnaider, Julia
    Zidan, Jamal
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (04) : E27 - E30
  • [25] Outcomes of First-Line Treatment in Patients with Advanced Clinical Stage Classic Hodgkin Lymphoma and Human Immunodeficiency Virus Infection
    Jose Del Moral, Juan
    Tuna, Elena
    Olivas, Antonio
    Aguayo, Alvaro
    Agreda, Gladys
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S250 - S251
  • [26] An open-label phase II study of sorafenib and dacarbazine as first-line therapy in patients with advanced melanoma
    Eisen, T.
    Marais, R.
    Affolter, A.
    Lorigan, P.
    Ottensmeier, C.
    Robert, C.
    Corrie, P.
    Chevreau, C.
    Erlandsson, F.
    Gore, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Phase II Clinical Trial of R-CHOP Combined with Lenalidomide in the First-Line Treatment for Patients with High Risk Diffuse Large B Cell Lymphoma
    Zhao, Shuang
    Zhang, Jiuyang
    Yan, Zheng
    Xu, Yuanlin
    Yao, Zhihua
    Chu, Junfeng
    Yao, Shuna
    Wang, Haiying
    Zhou, Wenping
    Luo, Xufeng
    Zhang, Peipei
    Liu, Yanyan
    BLOOD, 2023, 142
  • [28] Camrelizumab plus apatinib for advanced renal cell carcinoma patients after first-line tyrosine kinase inhibitor treatment failure: A multicenter phase II trial
    Jiang, Lijuan
    Zheng, Xia
    Wei, Wensu
    Peng, Yulu
    Wang, Deling
    Zhang, Zhiling
    Guo, Shengjie
    Han, Hui
    Cai, Xiuyu
    Zhou, Fangjian
    Dong, Pei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial
    Jain, Preetesh
    Young, Chi
    Nastoupil, Loretta J.
    Westin, Jason
    Hill, Holly A.
    Nair, Ranjit
    Iyer, Swami P.
    Fetooh, Ahmed
    Lee, Hun Ju
    Ahmed, Sairah
    Kanagal-Shamanna, Rashmi
    Jelloul, Fatima Z.
    Castillo, Luis Enrique Malpica
    Liu, Yang
    Li, Yijing
    Vargas, Jovanny
    Feng, Lei
    Badillo, Maria
    Thirumurthi, Selvi
    Xu, Guofan
    Deswal, Anita
    Iliescu, Cezar
    Nguyen, Vinh Quang
    Tang, Guilin
    Patel, Keyur P.
    Vega, Francisco
    Medeiros, L. Jeffrey
    Wang, Michael L.
    Flowers, Christopher R.
    BLOOD, 2023, 142
  • [30] ECHELON-1: three-year follow-up of the combination of brentuximab, vedotin and doxorubicin, vinblastine and dacarbazine as a first-line treatment for advanced stages of classical Hodgkin's lymphoma
    Chiche, Edmond
    Richez-Olivier, Valentine
    HEMATOLOGIE, 2020, 26 (02): : 97 - 98
12345